Patient no. | Tumor type | 68Ga-DOTATATE uptake (SUVmax) | 18F-FDG uptake (SUVmax) | Location of primary tumor | Size of primary tumor (cm) | Tumor site | Histology |
---|---|---|---|---|---|---|---|
1 | Primary | 33 | 7.2 | Central | 2.3 | Primary | Typical carcinoid |
2 | Primary | 8.2 | 6.7 | Central | 1.5 | Primary | Typical carcinoid |
3 | Primary | 44.9 | 2.3 | Central | 3.2 | Primary | Typical carcinoid |
4 | Primary | 18 | 2.9 | Central | 2.8 | Primary | Typical carcinoid |
5 | Primary | 29.4 | 2.9 | Central | 2.1 | Primary | Typical carcinoid |
6 | Primary | 45 | 3.4 | Central | 5.5 | Primary | Typical carcinoid |
7 | Primary | 118 | 16 | Central | 3.2 | Primary | Typical carcinoid |
8 | Primary | 12 | 4.9 | Peripheral | 2.6 | Primary | Typical carcinoid |
9 | Primary | 2.8 | 20.5 | Central | 8 | Primary, mediastinal node | Small cell neuroendocrine carcinoma |
10 | Primary | 42.7 | 6.3 | Central | 5.8 | Primary | Typical carcinoid |
11 | Primary | 65 | 6 | Central | 1.5 | Primary | Typical carcinoid |
12 | Recurrent metastatic | 24 | 1.7 | NA | — | Skeletal | Typical carcinoid |
13 | Primary | 1.0 | 1.1 | Multiple peripheral | 0.5 | Primary (multiple nodules) | Carcinoid tumorlets* |
14 | Primary | 2.2 | 18.5 | Peripheral | 4 | Lung, mediastinal node, liver | Large cell pulmonary neuroendocrine tumor |
15 | Primary | 1.5 | 1.5 | Central and peripheral | ≤1.3 | Lung | Multiple carcinoid tumorlets and tumors* |
16 | Recurrent metastatic | 5.1 | 11.7 | NA | — | Lung, chest wall, extrathoracic node | Atypical carcinoid |
17 | Recurrent metastatic | 4.7 | 14.5 | NA | — | Lung, mediastinal node, skeletal | Atypical carcinoid |
18 | Primary | 2.7 | 16 | Central | 2.8 | Primary, liver, skeletal | Adenocarcinoma with neuroendocrine differentiation |
↵* Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.
NA = not applicable.